Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders

20 Mar 2011

Abstract excerpt

Mayumi Naramura 1,2 , Scott Nadeau 1,2 , Bhopal Mohapatra 1,3 , Gulzar Ahmad 1 , Chandrani Mukhopadhyay 1 , Martin Sattler 5 , Srikumar M Raja 1 , Amarnath Natarajan 1,4 , Vimla Band 1,2 , Hamid Band 1,2,3 1 Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 2 Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21422499
DOI: 10.18632/oncotarget.233

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disordersPMID 21422499Read ↗

Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.Semantic proximity Read ↗

Role of CBL Mutations in Cancer and Non-Malignant PhenotypeSemantic proximity Read ↗

Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of AgeSemantic proximity Read ↗

The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategiesSemantic proximity Read ↗

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.Semantic proximity Read ↗

Mutations of c-Cbl in myeloid malignancies.Semantic proximity Read ↗

CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.Semantic proximity Read ↗

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.Semantic proximity Read ↗

Loss of function Cbl-c mutations in solid tumorsSemantic proximity Read ↗

CBL mutations promote activation of PI3K/AKT signaling via LYN kinaseSemantic proximity Read ↗

CBL mutations in pediatric solid and CNS tumors are a marker of receptor tyrosine kinase activation and a potential therapeutic targetSemantic proximity Read ↗

Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.